These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38377418)

  • 21. Myalgic Encephalomyelitis-Chronic Fatigue Syndrome Common Data Element item content analysis.
    Slavin MD; Bailey HM; Hickey EJ; Vasudevan A; Ledingham A; Tannenbaum L; Bateman L; Kaufman DL; Peterson DL; Ruhoy IS; Systrom DM; Felsenstein D; Kazis LE
    PLoS One; 2023; 18(9):e0291364. PubMed ID: 37698999
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of Gender Differences in HRV of Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Using Mobile-Health Technology.
    Capdevila L; Castro-Marrero J; Alegre J; Ramos-Castro J; Escorihuela RM
    Sensors (Basel); 2021 May; 21(11):. PubMed ID: 34071326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Typing myalgic encephalomyelitis by infection at onset: A DecodeME study.
    Bretherick AD; McGrath SJ; Devereux-Cooke A; Leary S; Northwood E; Redshaw A; Stacey P; Tripp C; Wilson J; Chowdhury S; Lewis I; Almelid Ø; Baby SV; Baker T; Becher H; Boutin T; Clyde M; Garcia D; Ireland J; Kerr SM; McDowall E; Perry D; Samms GL; Vitart V; Wolfe JC; Ponting CP
    NIHR Open Res; 2023; 3():20. PubMed ID: 37881452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Are Circulating Fibroblast Growth Factor 21 and N-Terminal Prohormone of Brain Natriuretic Peptide Promising Novel Biomarkers in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome?
    Domingo JC; Cordobilla B; Ferrer R; Giralt M; Alegre-Martín J; Castro-Marrero J
    Antioxid Redox Signal; 2021 Jun; 34(18):1420-1427. PubMed ID: 33353469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Numeric Rating Scales Show Prolonged Post-exertional Symptoms After Orthostatic Testing of Adults With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    van Campen CLMC; Rowe PC; Verheugt FWA; Visser FC
    Front Med (Lausanne); 2020; 7():602894. PubMed ID: 33585505
    [No Abstract]   [Full Text] [Related]  

  • 26. The Role of Autonomic Function in Exercise-induced Endogenous Analgesia: A Case-control Study in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Healthy People.
    Oosterwijck JV; Marusic U; De Wandele I; Paul L; Meeus M; Moorkens G; Lambrecht L; Danneels L; Nijs J
    Pain Physician; 2017 Mar; 20(3):E389-E399. PubMed ID: 28339438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In myalgic encephalomyelitis/chronic fatigue syndrome, increased autoimmune activity against 5-HT is associated with immuno-inflammatory pathways and bacterial translocation.
    Maes M; Ringel K; Kubera M; Anderson G; Morris G; Galecki P; Geffard M
    J Affect Disord; 2013 Sep; 150(2):223-30. PubMed ID: 23664637
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sex-specific plasma lipid profiles of ME/CFS patients and their association with pain, fatigue, and cognitive symptoms.
    Nkiliza A; Parks M; Cseresznye A; Oberlin S; Evans JE; Darcey T; Aenlle K; Niedospial D; Mullan M; Crawford F; Klimas N; Abdullah L
    J Transl Med; 2021 Aug; 19(1):370. PubMed ID: 34454515
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Health-related quality of life in patients with myalgic encephalomyelitis/chronic fatigue syndrome: an Australian cross-sectional study.
    Eaton-Fitch N; Johnston SC; Zalewski P; Staines D; Marshall-Gradisnik S
    Qual Life Res; 2020 Jun; 29(6):1521-1531. PubMed ID: 31970624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Health-Related Quality of Life for Patients with Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS).
    Falk Hvidberg M; Brinth LS; Olesen AV; Petersen KD; Ehlers L
    PLoS One; 2015; 10(7):e0132421. PubMed ID: 26147503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exercise-induce hyperalgesia, complement system and elastase activation in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome - a secondary analysis of experimental comparative studies.
    Polli A; Van Oosterwijck J; Meeus M; Lambrecht L; Nijs J; Ickmans K
    Scand J Pain; 2019 Jan; 19(1):183-192. PubMed ID: 30325737
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytokine profiling of extracellular vesicles isolated from plasma in myalgic encephalomyelitis/chronic fatigue syndrome: a pilot study.
    Giloteaux L; O'Neal A; Castro-Marrero J; Levine SM; Hanson MR
    J Transl Med; 2020 Oct; 18(1):387. PubMed ID: 33046133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychometric properties of the PROMIS
    Yang M; Keller S; Lin JS
    Qual Life Res; 2019 Dec; 28(12):3375-3384. PubMed ID: 31506915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Eukaryotes in the gut microbiota in myalgic encephalomyelitis/chronic fatigue syndrome.
    Mandarano AH; Giloteaux L; Keller BA; Levine SM; Hanson MR
    PeerJ; 2018; 6():e4282. PubMed ID: 29375937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating levels of GDF15 in patients with myalgic encephalomyelitis/chronic fatigue syndrome.
    Melvin A; Lacerda E; Dockrell HM; O'Rahilly S; Nacul L
    J Transl Med; 2019 Dec; 17(1):409. PubMed ID: 31801546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inflammatory and cell-mediated immune biomarkers in myalgic encephalomyelitis/chronic fatigue syndrome and depression: inflammatory markers are higher in myalgic encephalomyelitis/chronic fatigue syndrome than in depression.
    Maes M; Twisk FN; Ringel K
    Psychother Psychosom; 2012; 81(5):286-95. PubMed ID: 22832503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The utility of patient-reported outcome measures among patients with myalgic encephalomyelitis/chronic fatigue syndrome.
    Murdock KW; Wang XS; Shi Q; Cleeland CS; Fagundes CP; Vernon SD
    Qual Life Res; 2017 Apr; 26(4):913-921. PubMed ID: 27600520
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Poor sleep quality is associated with greater circulating pro-inflammatory cytokines and severity and frequency of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) symptoms in women.
    Milrad SF; Hall DL; Jutagir DR; Lattie EG; Ironson GH; Wohlgemuth W; Nunez MV; Garcia L; Czaja SJ; Perdomo DM; Fletcher MA; Klimas N; Antoni MH
    J Neuroimmunol; 2017 Feb; 303():43-50. PubMed ID: 28038892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) in three regions of England: a repeated cross-sectional study in primary care.
    Nacul LC; Lacerda EM; Pheby D; Campion P; Molokhia M; Fayyaz S; Leite JC; Poland F; Howe A; Drachler ML
    BMC Med; 2011 Jul; 9():91. PubMed ID: 21794183
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunological Patient Stratification in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Rohrhofer J; Hauser L; Lettenmaier L; Lutz L; Koidl L; Gentile SA; Ret D; Stingl M; Untersmayr E
    J Clin Med; 2024 Jan; 13(1):. PubMed ID: 38202282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.